bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Fig. S.3 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

MG1-IL-12-ICV induces systemic NK cell cytokines secretion.
Supplementary Figure 2 from Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Authors: Jeanbart Laura , Ballester Marie , de Titta Alexandre , Corthésy Patricia , Romero Pedro , Hubbell Jeffrey A. , Swartz Melody A.
Published: April 2023

PDF file - 51K, NP-conjugated OVA and CpG induces functional OVA257-264-specific CD8+ T cells and antibodies.
Supplementary Fig. S.1 from NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Authors: Alkayyal Almohanad A. , Tai Lee-Hwa , Kennedy Michael A. , de Souza Christiano Tanese , Zhang Jiqing , Lefebvre Charles , Sahi Shalini , Ananth Abhirami A. , Mahmoud Ahmad Bakur , Makrigiannis Andrew P. , Cron Greg O. , Macdonald Blair , Marginean E. Celia , Stojdl David F. , Bell John C. , Auer Rebecca C.
Published: April 2023

Sequences of IL12 conjoined regions of MG1-IL12 and G-less MRB-IL12 viruses.
supplementary table 4 from Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Authors: Wang Hao-Chen , Chen Chin-Wang , Yang Chia-Lung , Tsai I-Min , Hou Ya-Chin , Chen Chang-Jung , Shan Yan-Shen
Published: April 2023

Table S4. Expression of CD68 in 121 gastric tumors according to tumor stages
supplementary table 1 from Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Authors: Wang Hao-Chen , Chen Chin-Wang , Yang Chia-Lung , Tsai I-Min , Hou Ya-Chin , Chen Chang-Jung , Shan Yan-Shen
Published: April 2023

Table S1. Expression of GSN in 121 gastric tumors according to tumor stages
Supplementary data from Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Authors: Wang Hao-Chen , Chen Chin-Wang , Yang Chia-Lung , Tsai I-Min , Hou Ya-Chin , Chen Chang-Jung , Shan Yan-Shen
Published: April 2023

Supplementary Materials and Methods
Supplemental Figure 1 from Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
Authors: Heery Christopher R. , Singh B. Harpreet , Rauckhorst Myrna , Marté Jennifer L. , Donahue Renee N. , Grenga Italia , Rodell Timothy C. , Dahut William , Arlen Philip M. , Madan Ravi A. , Schlom Jeffrey , Gulley James L.
Published: April 2023

Yeast-brachyury progression-free survival; chordoma patients only.
Supplementary Figures 1 - 4 from HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
Authors: Woods David M. , Sodré Andressa L. , Villagra Alejandro , Sarnaik Amod , Sotomayor Eduardo M. , Weber Jeffrey
Published: April 2023

Supplemental Figure 1. HDAC inhibition upregulates PD-L1 in a melanoma cell line in a dose dependent manner. Supplemental Figure 2. DNA methyltransferase (DNMT) inhibitors increase PD-L1 and PD-L2 expression in melanoma. Supplemental Figure 3. Verification of patient melanomas. Supplemental Figure 4. In vivo LBH589 toxicity assessment.
Supplementary Information from The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Authors: Miyamoto Sho , Kochin Vitaly , Kanaseki Takayuki , Hongo Ayumi , Tokita Serina , Kikuchi Yasuhiro , Takaya Akari , Hirohashi Yoshihiko , Tsukahara Tomohide , Terui Takeshi , Ishitani Kunihiko , Hata Fumitake , Takemasa Ichiro , Miyazaki Akihiro , Hiratsuka Hiroyoshi , Sato Noriyuki , Torigoe Toshihiko
Published: April 2023

Supplementary Information
Supplementary Figures S1-S11 from Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Authors: Christmas Brian J. , Rafie Christine I. , Hopkins Alexander C. , Scott Blake A. , Ma Hayley S. , Cruz Kayla A. , Woolman Skylar , Armstrong Todd D. , Connolly Roisin M. , Azad Nilo A. , Jaffee Elizabeth M. , Roussos Torres Evanthia T.
Published: April 2023

This file contains supplemental figures that includes: FACS gating strategies; QC plots for NanoString cell typing; survival and tumor growth of neu-N mice receiving ENT and ICIs without ï�¡-HER2; circulating MDSCs and absolute numbers of G-MDSCs infiltrating neu-N and Panc02 tumors; G-MDSCs quantified using flow cytometry from neu-N tumors or from hepatic Panc02 metastases; MDSC functional markers by flow cytometry and expression of PD-L1 on G-MDSCs; patterns of myeloid cell functional markers on gene expression profiling; qPCR validation of NanoString, and T cell proliferation and IFNï�§ï€ production within the TME; western blots depicting protein expression levels of STAT3 and phospho-STAT3 and representative proteins from NanoString pathways; the exhaustion state of CD8+ T cells.
Supplementary Figure Legend from FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors
Authors: Cremasco Viviana , Astarita Jillian L. , Grauel Angelo L. , Keerthivasan Shilpa , MacIsaac Kenzie , Woodruff Matthew C. , Wu Michael , Spel Lotte , Santoro Stephen , Amoozgar Zohreh , Laszewski Tyler , Migoni Sara Cruz , Knoblich Konstantin , Fletcher Anne L. , LaFleur Martin , Wucherpfennig Kai W. , Pure Ellen , Dranoff Glenn , Carroll Michael C. , Turley Shannon J.
Published: April 2023

Figure legends for Supplementary Figures 1-8
Supplementary Figures and Legends from Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice
Authors: Tang Chih-Hang Anthony , Chang Shiun , Hashimoto Ayumi , Chen Yi-Ju , Kang Chang Won , Mato Anthony R. , Del Valle Juan R. , Gabrilovich Dmitry I. , Hu Chih-Chi Andrew
Published: April 2023

S1. Crosslinking and preparation of oligomeric HEL. S2. Oligomeric HEL crosslinks the BCR, and induces robust BCR signal transduction in MD4+/-/EÎ¼-TCL1+/+ B cells. S3. Oligomeric HEL activates a more rapid BCR signaling than F(ab')2 in MD4+/- and MD4+/-/EÎ¼-TCL1+/+ B cells. S4. CD11b+/Ly6G+ granulocytic cells or CD11b+/Ly6C+ monocytic cells do not accumulate in the blood and spleens of 6-month-old WT, MD4+/- and Î¼S-/- mice. S5. B cells and CLL cells from MD4+/-/EÎ¼-TCL1+/+ and EÎ¼-TCL1+/+ but not Î¼S-/-/Eï�­-TCL1+/+ mice produce sIgM; human CLL cells also produce and secrete IgM. S6. Decreased percentages of CD11b+/Ly6G+ granulocytic cells in spleens of 6-week-old Î¼S-/-/Eï�­-TCL1+/+ mice; decreased percentages of CD11b+/Ly6G+ granulocytic cells and CD11b+/Ly6C+ monocytic cells in the bone marrow of 6-month-old Î¼S-/-/EÎ¼-TCL1+/+ mice; increased percentages of CD11b+/Ly6G+ granulocytic cells and CD11b+/Ly6C+ monocytic cells in the bone marrow of 6-week-old MD4+/-/EÎ¼-TCL1+/+ mice; and increased percentages of CD11b+/Ly6G+ granulocytic cells in the bone marrow of 6-month-old MD4+/-/EÎ¼-TCL1+/+ mice. S7. CD11b+/Ly6G+ granulocytic cells can be purified from the spleens and peripheral blood of MD4+/-/EÎ¼ï�­-TCL1+/+ mice. S8. CD11b+/Ly6G+ granulocytic cells purified from the spleens or bone marrow of LLC-grafted WT and Î¼S-/- mice have small or little effect in suppressing T cell proliferation.
Figure S5 from Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
Authors: Oh Ji Hoon , Kim Myeong Joon , Choi Seong Jin , Ban Young Ho , Lee Heung Kyu , Shin Eui-Cheol , Lee Kyung-Mi , Ha Sang-Jun
Published: April 2023

Figure S5. shows the efficacy of depleting antibodies and the viral titers after treatment of depleting antibodies.
Figure S1 from Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
Authors: Oh Ji Hoon , Kim Myeong Joon , Choi Seong Jin , Ban Young Ho , Lee Heung Kyu , Shin Eui-Cheol , Lee Kyung-Mi , Ha Sang-Jun
Published: April 2023

Figure S1. shows NK cell phenotypes at different time points after chronic LCMV infection.
Suppl. Figure from RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells
Authors: Rizzo Angelamaria , Di Giovangiulio Martina , Stolfi Carmine , Franzè Eleonora , Fehling Hans-Joerg , Carsetti Rita , Giorda Ezio , Colantoni Alfredo , Ortenzi Angela , Rugge Massimo , Mescoli Claudia , Monteleone Giovanni , Fantini Massimo C.
Published: April 2023

Suppl. figure and figure legends
Video 4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Video 4
Video 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
Authors: Gui Philippe , Ben-Neji Myriam , Belozertseva Ekaterina , Dalenc Florence , Franchet Camille , Gilhodes Julia , Labrousse Arnaud , Bellard Elisabeth , Golzio Muriel , Poincloux Renaud , Maridonneau-Parini Isabelle , Le Cabec Véronique
Published: April 2023

Video 1
Supplemental Figure Legends from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
Authors: Morris Zachary S. , Guy Emily I. , Werner Lauryn R. , Carlson Peter M. , Heinze Clinton M. , Kler Jasdeep S. , Busche Sara M. , Jaquish Abigail A. , Sriramaneni Raghava N. , Carmichael Lakeesha L. , Loibner Hans , Gillies Stephen D. , Korman Alan J. , Erbe Amy K. , Hank Jacquelyn A. , Rakhmilevich Alexander L. , Harari Paul M. , Sondel Paul M.
Published: April 2023

Supplemental Figure Legends
Figure S3 from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
Authors: Morris Zachary S. , Guy Emily I. , Werner Lauryn R. , Carlson Peter M. , Heinze Clinton M. , Kler Jasdeep S. , Busche Sara M. , Jaquish Abigail A. , Sriramaneni Raghava N. , Carmichael Lakeesha L. , Loibner Hans , Gillies Stephen D. , Korman Alan J. , Erbe Amy K. , Hank Jacquelyn A. , Rakhmilevich Alexander L. , Harari Paul M. , Sondel Paul M.
Published: April 2023

The presence of an untreated secondary tumor influences the effect of RT on the ratio of tumor infiltrating CD8+:FoxP3+ cells at a radiated tumor site.
Supplementary Figure S4 from PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Authors: Concha-Benavente Fernando , Kansy Benjamin , Moskovitz Jessica , Moy Jennifer , Chandran Uma , Ferris Robert L.
Published: April 2023

Supplementary Figure S4
Figure S1 from Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo
Authors: Eisenberg Galit , Engelstein Roni , Geiger-Maor Anat , Hajaj Emma , Merims Sharon , Frankenburg Shoshana , Uzana Ronny , Rutenberg Abraham , Machlenkin Arthur , Frei Gabi , Peretz Tamar , Lotem Michal
Published: April 2023

SLAMF6 expression on human lymphocytes
Supplementary Legends from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

Supplementary Legends
Figure S4 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

Transfer of CD4+ T cells from CD4creHsp90b1flox/flox mice to immuno-deficient hosts indicates activation defect
Figure S3 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function
Authors: Thaxton Jessica E. , Wallace Caroline , Riesenberg Brian , Zhang Yongliang , Paulos Chrystal M. , Beeson Craig C. , Liu Bei , Li Zihai
Published: April 2023

Characterization of WT contaminant cells in CD4creHsp90b1flox/flox mice
Supplementary Table 1 from A Mechanism of Resistance to Antibody-Targeted Immune Attack
Authors: Aldeghaither Dalal S. , Zahavi David J. , Murray Joseph C. , Fertig Elana J. , Graham Garrett T. , Zhang Yong-Wei , O'Connell Allison , Ma Junfeng , Jablonski Sandra A. , Weiner Louis M.
Published: April 2023

Supplementary Table 1
Figure S1 - S7 from Subcellular Localization of Antigen in Keratinocytes Dictates Delivery of CD4+ T-cell Help for the CTL Response upon Therapeutic DNA Vaccination into the Skin
Authors: Bąbała Nikolina , Bovens Astrid , de Vries Evert , Iglesias-Guimarais Victoria , Ahrends Tomasz , Krummel Matthew F. , Borst Jannie , Bins Adriaan D.
Published: April 2023

Supplemental Figures and Legends
Supplementary Figure 6 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

Flow cytometry gating strategy for identifying Foxp3 expression in CD4+ T cells and PD-1, CD44, and CD69 on CD8+ T cells
Supplementary Figure 3 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

Flow gating strategy for identification of PD-L1(high) cells in the TME
Supplementary Figure 1 from The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Authors: Li Howard Y. , McSharry Maria , Bullock Bonnie , Nguyen Teresa T. , Kwak Jeff , Poczobutt Joanna M. , Sippel Trisha R. , Heasley Lynn E. , Weiser-Evans Mary C. , Clambey Eric T. , Nemenoff Raphael A.
Published: April 2023

Direct DNA sequencing chromatograms of Kras in CMT167, LLC, and LL/2 cells
Figure S2 from TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway
Authors: Zizzari Ilaria Grazia , Napoletano Chiara , Botticelli Andrea , Caponnetto Salvatore , Calabrò Fabio , Gelibter Alain , Rughetti Aurelia , Ruscito Ilary , Rahimi Hassan , Rossi Ernesto , Schinzari Giovanni , Marchetti Paolo , Nuti Marianna
Published: April 2023

A) T cell analysis cultured up to 24 hours with pazopanib and sunitinib. B)VEGF-R1 expression on T cells
Supplementary Figure 6 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Authors: Kim Min Hwan , Kim Chang Gon , Kim Sang-Kyum , Shin Sang Joon , Choe Eun Ah , Park Su-Hyung , Shin Eui-Cheol , Kim Joon
Published: April 2023

S6. PD-1/PD-L1 interaction is responsible of YAP-mediated immune evasion from Melan-A-specific CD8+ T cells.
Supplementary Figure 2 from YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Authors: Kim Min Hwan , Kim Chang Gon , Kim Sang-Kyum , Shin Sang Joon , Choe Eun Ah , Park Su-Hyung , Shin Eui-Cheol , Kim Joon
Published: April 2023

S2. Influence of YAP-5SA expression on PD-L1 surface expression in cancer cell lines of various origins other than melanoma: breast cancer (MCF7 and MDA-MB231), non-small cell lung cancer (A549), colon cancer (HT29 and KM12), and glioblastoma (A172).
Supplementary Figures 1-6 from Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells
Authors: Rodrigues Neidy V. , Correia Daniel V. , Mensurado Sofia , Nóbrega-Pereira Sandrina , deBarros Ana , Kyle-Cezar Fernanda , Tutt Andrew , Hayday Adrian C. , Norell Haakan , Silva-Santos Bruno , Dias Sérgio
Published: April 2023

S1. LDL-cholesterol does not affect the viability of human Î³Î' T cells. S2. Effects of LDL-cholesterol on Vï�¤2+ T cells after 36 or 48 hours of culture. S3. Effects of LDL-cholesterol on additional immune functions of Î³Î' T cells. S4. Effect of LDL-cholesterol on expanded VÎ³9VÎ'2 T cells cultured in the presence of human plasma. S5. Effects of receptor blockade on breast cancer cell targeting by Î³Î' T lymphocytes. S6: Cholesterol-rich diet reduces multifunctional anti-tumour Î³Î' infiltrating lymphocytes.
Supplementary Figure Legends from PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
Authors: Whelan Sarah , Ophir Eran , Kotturi Maya F. , Levy Ofer , Ganguly Sudipto , Leung Ling , Vaknin Ilan , Kumar Sandeep , Dassa Liat , Hansen Kyle , Bernados David , Murter Benjamin , Soni Abha , Taube Janis M. , Fader Amanda Nickles , Wang Tian-Li , Shih Ie-Ming , White Mark , Pardoll Drew M. , Liang Spencer C.
Published: April 2023

Figure captions
Figure S2 from NK Cells Control Tumor-Promoting Function of Neutrophils in Mice
Authors: Ogura Keisuke , Sato-Matsushita Marimo , Yamamoto Seiji , Hori Takashi , Sasahara Masakiyo , Iwakura Yoichiro , Saiki Ikuo , Tahara Hideaki , Hayakawa Yoshihiro
Published: April 2023

Supplementary Figure 2. No alteration in the phenotype of tumor-infiltrated CTL.
Supplemental Material from Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
Authors: Shitaoka Kiyomi , Hamana Hiroshi , Kishi Hiroyuki , Hayakawa Yoshihiro , Kobayashi Eiji , Sukegawa Kenta , Piao Xiuhong , Lyu Fulian , Nagata Takuya , Sugiyama Daisuke , Nishikawa Hiroyoshi , Tanemura Atsushi , Katayama Ichiro , Murahashi Mutsunori , Takamatsu Yasushi , Tani Kenzaburo , Ozawa Tatsuhiko , Muraguchi Atsushi
Published: April 2023

S1. The expression of CD137 on splenic CD8+ T cells and the expression of PD1 and CD137 on CD8+ TILs of tumor bearing mice. S2. Analysis of TILs. (A) CD137 expression of TILs and RLN cells. S3. Transfection of TCR cDNA into splenic T cells. S4. IFN-γ-induced expression of MHC class I molecules on the surface of B16F10 cells. S5. The IFN-γ-secretion of TIL-derived TCR-transduced spleen T cells. S6. The cytotoxicity of TIL-derived TCR-expressing T cells against unstimulated B16F10 cells. S7. A correlation between the INF-γ production and the cytotoxicity. S8. Transfection efficiency of TCR gene into splenic T cellsforin vivoexperiment. S9. MHC-restriction of TIL-derived TCR. (A) Expression of H-2Kband H-2Dbmolecules on H-2Kbor H-2DbcDNA-transfected B16F10 cells. S10. IFN-γ-induced expression of MHC class I molecules on the surface of cells. Supplementary Table 1. Clonally expanded populations in human cancer TILs
Suppl Figure 5 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma
Authors: Solomon Benjamin , Young Richard J. , Bressel Mathias , Urban Damien , Hendry Shona , Thai Alesha , Angel Christopher , Haddad Afaf , Kowanetz Marcin , Fua Tsien , Corry June , Fox Stephen , Rischin Danny
Published: April 2023

Dual stain example
Supplemental Tables 1 and 2 from Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells
Authors: Fragale Alessandra , Romagnoli Giulia , Licursi Valerio , Buoncervello Maria , Del Vecchio Giorgia , Giuliani Caterina , Parlato Stefania , Leone Celeste , De Angelis Marta , Canini Irene , Toschi Elena , Belardelli Filippo , Negri Rodolfo , Capone Imerio , Presutti Carlo , Gabriele Lucia
Published: April 2023

Supplementary Table 1. Sequences of oligonucleotides used in RT-qPCR are listed. Supplementary Table 2. Sequences of oligonucleotides used in ChIP assays in qPCR.
Table S1 from Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Authors: Zhang Jennifer Q. , Zeng Shan , Vitiello Gerardo A. , Seifert Adrian M. , Medina Benjamin D. , Beckman Michael J. , Loo Jennifer K. , Santamaria-Barria Juan , Maltbaek Joanna H. , Param Nesteene J. , Moral John A. , Zhao Julia N. , Balachandran Vinod , Rossi Ferdinand , Antonescu Cristina R. , DeMatteo Ronald P.
Published: April 2023

Human GIST characteristics
Figure S2 from Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Authors: Zhang Jennifer Q. , Zeng Shan , Vitiello Gerardo A. , Seifert Adrian M. , Medina Benjamin D. , Beckman Michael J. , Loo Jennifer K. , Santamaria-Barria Juan , Maltbaek Joanna H. , Param Nesteene J. , Moral John A. , Zhao Julia N. , Balachandran Vinod , Rossi Ferdinand , Antonescu Cristina R. , DeMatteo Ronald P.
Published: April 2023

AFS98 depletion
Figure S1 from Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Authors: Zhang Jennifer Q. , Zeng Shan , Vitiello Gerardo A. , Seifert Adrian M. , Medina Benjamin D. , Beckman Michael J. , Loo Jennifer K. , Santamaria-Barria Juan , Maltbaek Joanna H. , Param Nesteene J. , Moral John A. , Zhao Julia N. , Balachandran Vinod , Rossi Ferdinand , Antonescu Cristina R. , DeMatteo Ronald P.
Published: April 2023

Gating strategy
Supplemental Figures S1-S5 from A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells In Vivo
Authors: Szyska Martin , Herda Stefanie , Althoff Stefanie , Heimann Andreas , Russ Josefine , D'Abundo Daniele , Dang Tra My , Durieux Isabell , Dörken Bernd , Blankenstein Thomas , Na Il-Kang
Published: April 2023

Figure S1 - The NFAT-CBR reporter reveals systemic alloreactivity in a major mismatch model. Figure S2 - The NFAT-CBR reporter in response to specific antigen. Figure S3 - Homeostatic expansion of BLITC T cells in in vivo. Figure S4 - CRISPR-Cas9 mediated loss of function mutation of TagLuc in 200.09 cells. Figure S5 - Titration of Marilyn T cells in the anti-tumor response and inhibitory receptors on TILs.
Supplementary Figure S7 from Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Authors: Hennequart Marc , Pilotte Luc , Cane Stefania , Hoffmann Delia , Stroobant Vincent , Plaen Etienne De , Eynde Benoît J. Van den
Published: April 2023

Treatment of SKOV3 cells with celecoxib represses IDO1 expression and tryptophan degradation, and restores proliferation of co-incubated allogeneic lymphocytes (PBL).
Supplementary Figure 4 from Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation
Authors: Borrelli Cristiana , Ricci Biancamaria , Vulpis Elisabetta , Fionda Cinzia , Ricciardi Maria Rosaria , Petrucci Maria Teresa , Masuelli Laura , Peri Agnese , Cippitelli Marco , Zingoni Alessandra , Santoni Angela , Soriani Alessandra
Published: April 2023

Fig S4. MEL-treated ARK cells elicit NK cell activation and proliferation by IL-15 trans-presentation
Supplementary Figure 1 from Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation
Authors: Borrelli Cristiana , Ricci Biancamaria , Vulpis Elisabetta , Fionda Cinzia , Ricciardi Maria Rosaria , Petrucci Maria Teresa , Masuelli Laura , Peri Agnese , Cippitelli Marco , Zingoni Alessandra , Santoni Angela , Soriani Alessandra
Published: April 2023

Fig S1. MM cells acquire a senescent phenotype upon genotoxic drug treatment.
Supplementary Tables and Figures from Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer
Authors: Nearchou Ines P. , Lillard Kate , Gavriel Christos G. , Ueno Hideki , Harrison David J. , Caie Peter D.
Published: April 2023

Supplementary Tables and Figures
Table S3 from Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
Authors: Iorgulescu J. Bryan , Harary Maya , Zogg Cheryl K. , Ligon Keith L. , Reardon David A. , Hodi F. Stephen , Aizer Ayal A. , Smith Timothy R.
Published: April 2023

Table S3
Supplementary Figure legends from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
Authors: Beavis Paul A. , Henderson Melissa A. , Giuffrida Lauren , Davenport Alexander J. , Petley Emma V. , House Imran G. , Lai Junyun , Sek Kevin , Milenkovski Nicole , John Liza B. , Mardiana Sherly , Slaney Clare Y. , Trapani Joseph A. , Loi Sherene , Kershaw Michael H. , Haynes Nicole M. , Darcy Phillip K.
Published: April 2023

Supplementary Figure legends
Figure S4 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
Authors: Beavis Paul A. , Henderson Melissa A. , Giuffrida Lauren , Davenport Alexander J. , Petley Emma V. , House Imran G. , Lai Junyun , Sek Kevin , Milenkovski Nicole , John Liza B. , Mardiana Sherly , Slaney Clare Y. , Trapani Joseph A. , Loi Sherene , Kershaw Michael H. , Haynes Nicole M. , Darcy Phillip K.
Published: April 2023

Supplementary Figure 4
Figure S4 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors
Authors: Francica Brian J. , Ghasemzadeh Ali , Desbien Anthony L. , Theodros Debebe , Sivick Kelsey E. , Reiner Gabrielle L. , Hix Glickman Laura , Marciscano Ariel E. , Sharabi Andrew B. , Leong Meredith L. , McWhirter Sarah M. , Dubensky Thomas W. , Pardoll Drew M. , Drake Charles G.
Published: April 2023

S4: TNFα blockade reduces necrosis after IT CDN.
Figure S1 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
Authors: Beavis Paul A. , Henderson Melissa A. , Giuffrida Lauren , Davenport Alexander J. , Petley Emma V. , House Imran G. , Lai Junyun , Sek Kevin , Milenkovski Nicole , John Liza B. , Mardiana Sherly , Slaney Clare Y. , Trapani Joseph A. , Loi Sherene , Kershaw Michael H. , Haynes Nicole M. , Darcy Phillip K.
Published: April 2023

Supplementary Figure 1
Supplementary Figures 1-5 from Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells
Authors: Liu Lisa L. , Béziat Vivien , Oei Vincent Y.S. , Pfefferle Aline , Schaffer Marie , Lehmann Sören , Hellström-Lindberg Eva , Söderhäll Stefan , Heyman Mats , Grandér Dan , Malmberg Karl-Johan
Published: April 2023

Supplementary Figure 1. Expansion of adaptive NK cells from C1/C2 donors depends on original imprint. Supplemental Figure 2. Selective expansion of NKG2C NKG2A- NK cells depends on stimulation with HLA-E expressing feeder cells. Supplementary Figure 3. Expression of granzymes and perforin before and after in vitro expansion of adaptive NK cells. Supplementary Figure 4. Adaptive NK cells recognize MDS and AML blasts. Supplementary Figure 5. Sorting of adaptive NK cells for functional studies.
Table S4 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
Authors: Nath Pulak Ranjan , Pal-Nath Dipasmita , Mandal Ajeet , Cam Margaret C. , Schwartz Anthony L. , Roberts David D.
Published: April 2023

Supplemental Table 4. NK cells were negatively enriched from pooled spleens of 3 WT and 3 Cd47-/- littermate mice and cultured with/out thrombospondin-1 (2nM) for 24 hours in RPMI (without FCS) + IL-15 (2.5 ng/ml). Golgi-stop was added at last 4 hours of culture. FcRs were blocked with rat and rabbit serum and cell surface CD47 and NK1.1 were stained with Aqua Live/Dead. Cells were then fixed, permeabilized and i.c. stained for Ki-67, IL-2, IFNγ, TNFα and GzmB. Values indicate the MFI of indicated proteins.
Supplementary Figure S6 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

S6. A12-IFNγ alters the tumor microenvironment in KPC organoid model of pancreatic cancer.
Supplementary Figure S5 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

S5. Combination B3-IL2 and A12-IFNγ has additive benefit over either agent alone.
Supplementary Data Description from A Multikinase and DNA-PK Inhibitor Combination Immunomodulates Melanomas, Suppresses Tumor Progression, and Enhances Immunotherapies
Authors: Tsai Alexander K. , Khan Asra Y. , Worgo Christina E. , Wang Lucy L. , Liang Yuanyuan , Davila Eduardo
Published: April 2023

Supplementary Data Description
Supplementary Figure S3 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

S3. Single agent treatment with B3 does not alter B16 growth in vivo.
Supplementary Table 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
Authors: Frazao Alexandra , Messaoudene Meriem , Nunez Nicolas , Dulphy Nicolas , Roussin France , Sedlik Christine , Zitvogel Laurence , Piaggio Eliane , Toubert Antoine , Caignard Anne
Published: April 2023

Supplementary Table 1
Supplementary Figure 5 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
Authors: Frazao Alexandra , Messaoudene Meriem , Nunez Nicolas , Dulphy Nicolas , Roussin France , Sedlik Christine , Zitvogel Laurence , Piaggio Eliane , Toubert Antoine , Caignard Anne
Published: April 2023

Supplementary Figure 5
Figure S4 from Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Authors: Polesso Fanny , Weinberg Andrew D. , Moran Amy E.
Published: April 2023

Figure S4 shows that tumor-infiltrating Tregs isolated from combination therapy treated tumors suppress T cell proliferation to the same extend as those isolated from control treated tumors.
Figure S2 from Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8+ T Cells
Authors: Hurst Katie E. , Lawrence Kiley A. , Essman Matthew T. , Walton Zeke J. , Leddy Lee R. , Thaxton Jessica E.
Published: April 2023

mtROS+ CD8 TILs are highly activated
Supplementary Figures from NKT Cell–Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion
Authors: Lam Pui Yeng , Kobayashi Takumi , Soon Megan , Zeng Bijun , Dolcetti Riccardo , Leggatt Graham , Thomas Ranjeny , Mattarollo Stephen R.
Published: April 2023

Supplementary Figures 1-3
List of KPC Peptides from Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model
Authors: Narayanan Jayanth S. Shankara , Ray Partha , Hayashi Tomoko , Whisenant Thomas C. , Vicente Diego , Carson Dennis A. , Miller Aaron M. , Schoenberger Stephen P. , White Rebekah R.
Published: April 2023

List of KPC Peptides
Supplemental Data File 1 from Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Authors: Smith Christof C. , Chai Shengjie , Washington Amber R. , Lee Samuel J. , Landoni Elisa , Field Kevin , Garness Jason , Bixby Lisa M. , Selitsky Sara R. , Parker Joel S. , Savoldo Barbara , Serody Jonathan S. , Vincent Benjamin G.
Published: April 2023

Supplemental Data File
Supplementary Tables from Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma
Authors: Nejo Takahide , Matsushita Hirokazu , Karasaki Takahiro , Nomura Masashi , Saito Kuniaki , Tanaka Shota , Takayanagi Shunsaku , Hana Taijun , Takahashi Satoshi , Kitagawa Yosuke , Koike Tsukasa , Kobayashi Yukari , Nagae Genta , Yamamoto Shogo , Ueda Hiroki , Tatsuno Kenji , Narita Yoshitaka , Nagane Motoo , Ueki Keisuke , Nishikawa Ryo , Aburatani Hiroyuki , Mukasa Akitake , Saito Nobuhito , Kakimi Kazuhiro
Published: April 2023

Supplementary Tables 1-13
Figure S4 from Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer
Authors: Ye Jian , Mills Bradley N. , Zhao Tony , Han Booyeon J. , Murphy Joseph D. , Patel Ankit P. , Johnston Carl J. , Lord Edith M. , Belt Brian A. , Linehan David C. , Gerber Scott A.
Published: April 2023

Supplemental figure 4
Supplementary Tables from IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development
Authors: Riva Federica , Ponzoni Maurilio , Supino Domenico , Bertilaccio Maria Teresa Sabrina , Polentarutti Nadia , Massara Matteo , Pasqualini Fabio , Carriero Roberta , Innocenzi Anna , Anselmo Achille , Veliz-Rodriguez Tania , Simonetti Giorgia , Anders Hans-Joachim , Caligaris-Cappio Federico , Mantovani Alberto , Muzio Marta , Garlanda Cecilia
Published: April 2023

Supplementary tables 1-5
Figure S2 from The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer
Authors: Spinner Camille A. , Lamsoul Isabelle , Métais Arnaud , Febrissy Chanaëlle , Moog-Lutz Christel , Lutz Pierre G.
Published: April 2023

Figure S2 shows the numbers of Î³Î' T, IFN-Î³+ Î³Î' T, NK and IFN-Î³+ NK cells in the colon of control and cKO mice treated with AOM and DSS.
Figure S1 from The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer
Authors: Spinner Camille A. , Lamsoul Isabelle , Métais Arnaud , Febrissy Chanaëlle , Moog-Lutz Christel , Lutz Pierre G.
Published: April 2023

Figure S1 shows the numbers of dendritic cells, macrophages and B cells in the colon, and the numbers of dendritic cells in the mesenteric lymph nodes of control and cKO mice treated with AOM and DSS.
Supplementary Figure Legends from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure Legends
Supplementary Figure 6 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure 6
Figure S4 from Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA
Authors: Kundu Kiran , Ghosh Susmita , Sarkar Rhitajit , Edri Avishay , Brusilovsky Michael , Gershoni-Yahalom Orly , Yossef Rami , Shemesh Avishai , Soria Jean-Charles , Lazar Vladimir , Joshua Ben-Zion , Campbell Kerry S. , Elkabets Moshe , Porgador Angel
Published: April 2023

Activation of pNF-kB by 14-25-9.
Supplementary Figures from CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner
Authors: Leblond Marine M. , Tillé Laure , Nassiri Sina , Gilfillan Connie B. , Imbratta Claire , Schmittnaegel Martina , Ries Carola H. , Speiser Daniel E. , Verdeil Grégory
Published: April 2023

Supplementary Figures S1-S10
Supplementary Figure 3 from A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Authors: Rogers Laura M. , Wang Zhaoming , Mott Sarah L. , Dupuy Adam J. , Weiner George J.
Published: April 2023

Tumor sizes at endpoint by treatment group
Supplementary Data from BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Authors: Smith Eric L. , Mailankody Sham , Staehr Mette , Wang Xiuyan , Senechal Brigitte , Purdon Terence J. , Daniyan Anthony F. , Geyer Mark B. , Goldberg Aaron D. , Mead Elena , Santomasso Bianca D. , Landa Jonathan , Rimner Andreas , Riviere Isabelle , Landgren Ola , Brentjens Renier J.
Published: April 2023

Supplementary Data Combined
Supplementary Figures and Legends from Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer
Authors: Chen Baosheng , Alvarado David M. , Iticovici Micah , Kau Nathan S. , Park Haeseong , Parikh Parag J. , Thotala Dinesh , Ciorba Matthew A.
Published: April 2023

Supplementary Figures and Legends
Supplementary Movie 1 from CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance
Authors: Mondini Michele , Loyher Pierre-Louis , Hamon Pauline , Gerbé de Thoré Marine , Laviron Marie , Berthelot Kevin , Clémenson Céline , Salomon Benoit L. , Combadière Christophe , Deutsch Eric , Boissonnas Alexandre
Published: April 2023

Intravital biphoton microscopy analysis of explanted TC1/Luc tumors from MacBlue/Foxp3-EGFP mice was performed at 5 days after radiotherapy. Time-lapse TPLSM video sequence from a representative field showing multiple interactions between Tregs and monocytes.
Figure S3 from T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity
Authors: Sharma Preeti , Harris Daniel T. , Stone Jennifer D. , Kranz David M.
Published: April 2023

Supplementary Figure S3: Reactivity of T1 or RD1 TCR transduced CD8+ T cells with human peptides containing central "GIG" motif.
Supplementary Table S2 from Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Authors: Tomita Yusuke , Ikeda Tokunori , Sakata Shinya , Saruwatari Koichi , Sato Ryo , Iyama Shinji , Jodai Takayuki , Akaike Kimitaka , Ishizuka Shiho , Saeki Sho , Sakagami Takuro
Published: April 2023

Indications and characteristics of probiotic CBT in NSCLC patients (N=39).
Supplementary Table S1 from Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Authors: Tomita Yusuke , Ikeda Tokunori , Sakata Shinya , Saruwatari Koichi , Sato Ryo , Iyama Shinji , Jodai Takayuki , Akaike Kimitaka , Ishizuka Shiho , Saeki Sho , Sakagami Takuro
Published: April 2023

The relationship between probiotic CBT and the incidence of immune-related enterocolitis/diarrhea during ICI therapy.
Supplementary Figures from Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer
Authors: Ge Yingzi , Böhm Hans-Henning , Rathinasamy Anchana , Xydia Maria , Hu Xiaoying , Pincha Mudita , Umansky Ludmila , Breyer Christopher , Hillier Michael , Bonertz Andreas , Sevko Alexandra , Domschke Christoph , Schuetz Florian , Frebel Helge , Dettling Steffen , Herold-Mende Christel , Reissfelder Christoph , Weitz Jürgen , Umansky Viktor , Beckhove Philipp
Published: April 2023

Supplemental Figures S1 to S12
Figure legend S1-S9 from IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells
Authors: Toyoshima Yujiro , Kitamura Hidemitsu , Xiang Huihui , Ohno Yosuke , Homma Shigenori , Kawamura Hideki , Takahashi Norihiko , Kamiyama Toshiya , Tanino Mishie , Taketomi Akinobu
Published: April 2023

Supplementary Figure legends_R2
Supplementary Data from T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors
Authors: Krawczyk Eric , Zolov Sergey N. , Huang Kevin , Bonifant Challice L.
Published: April 2023

Supplementary Figures 1-7
Supplementary Tables from Anti–PD-1–Induced Pneumonitis Is Associated with Persistent Imaging Abnormalities in Melanoma Patients
Authors: Johnson Douglas B. , Taylor Kevin B. , Cohen Justine V. , Ayoubi Noura , Haugh Alexandra M. , Wang Daniel Y. , Schlick Brian D. , Voorhees Amber L. , Gage Kenneth L. , Fintelmann Florian J. , Sullivan Ryan J. , Eroglu Zeynep , Abramson Richard G.
Published: April 2023

Supplementary Table 1
Supplementary Legends from Anti–PD-1–Induced Pneumonitis Is Associated with Persistent Imaging Abnormalities in Melanoma Patients
Authors: Johnson Douglas B. , Taylor Kevin B. , Cohen Justine V. , Ayoubi Noura , Haugh Alexandra M. , Wang Daniel Y. , Schlick Brian D. , Voorhees Amber L. , Gage Kenneth L. , Fintelmann Florian J. , Sullivan Ryan J. , Eroglu Zeynep , Abramson Richard G.
Published: April 2023

Legends for supplementary figures 1 and 2
Supplementary Figures from Anti–PD-1–Induced Pneumonitis Is Associated with Persistent Imaging Abnormalities in Melanoma Patients
Authors: Johnson Douglas B. , Taylor Kevin B. , Cohen Justine V. , Ayoubi Noura , Haugh Alexandra M. , Wang Daniel Y. , Schlick Brian D. , Voorhees Amber L. , Gage Kenneth L. , Fintelmann Florian J. , Sullivan Ryan J. , Eroglu Zeynep , Abramson Richard G.
Published: April 2023

Supplementary figures 1-2
Supplementary Table S1 from Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
Authors: Ree Anne Hansen , Nygaard Vigdis , Russnes Hege G. , Heinrich Daniel , Nygaard Vegard , Johansen Christin , Bergheim Inger Riise , Hovig Eivind , Beiske Klaus , Negård Anne , Børresen-Dale Anne-Lise , Flatmark Kjersti , Mælandsmo Gunhild M.
Published: April 2023

Supplementary Table S1
Supplementary Table S2 from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
Authors: Terry Stéphane , Abdou Abderemane , Engelsen Agnete S.T. , Buart Stéphanie , Dessen Philippe , Corgnac Stéphanie , Collares Davi , Meurice Guillaume , Gausdal Gro , Baud Véronique , Saintigny Pierre , Lorens James B. , Thiery Jean-Paul , Mami-Chouaib Fathia , Chouaib Salem
Published: April 2023

Supplementary Table S2
Supplementary Data from Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner
Authors: Shi Lewis Zhichang , Goswami Sangeeta , Fu Tihui , Guan Baoxiang , Chen Jianfeng , Xiong Liangwen , Zhang Jan , Ng Tang Derek , Zhang Xuejun , Vence Luis , Blando Jorge , Allison James P. , Collazo Renata , Gao Jianjun , Sharma Padmanee
Published: April 2023

Supplementary Figure and Figure Legends
Fig S5 from A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity
Authors: Ye Shiming , Cohen Diane , Belmar Nicole A. , Choi Donghee , Tan Siu Sze , Sho Mien , Akamatsu Yoshiko , Kim Han , Iyer Ramesh , Cabel Jean , Lake Marc , Song Danying , Harlan John , Zhang Catherine , Fang Yuni , Wahl Alan F. , Culp Patricia , Hollenbaugh Diane , Chao Debra T.
Published: April 2023

PC3 cells stably expressing different levels of MSLN
Fig S2 from A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity
Authors: Ye Shiming , Cohen Diane , Belmar Nicole A. , Choi Donghee , Tan Siu Sze , Sho Mien , Akamatsu Yoshiko , Kim Han , Iyer Ramesh , Cabel Jean , Lake Marc , Song Danying , Harlan John , Zhang Catherine , Fang Yuni , Wahl Alan F. , Culp Patricia , Hollenbaugh Diane , Chao Debra T.
Published: April 2023

Soluble and cell surface expressed MSLN in 4T1-MSLN model and combination treatment with anti-CD40 and anti-MSLN
Fig S1 from A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity
Authors: Ye Shiming , Cohen Diane , Belmar Nicole A. , Choi Donghee , Tan Siu Sze , Sho Mien , Akamatsu Yoshiko , Kim Han , Iyer Ramesh , Cabel Jean , Lake Marc , Song Danying , Harlan John , Zhang Catherine , Fang Yuni , Wahl Alan F. , Culp Patricia , Hollenbaugh Diane , Chao Debra T.
Published: April 2023

Binding and ADCC function of ABBV-428
Supplementary Table S6 from Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma
Authors: Faridi Pouya , Woods Katherine , Ostrouska Simone , Deceneux Cyril , Aranha Ritchlynn , Duscharla Divya , Wong Stephen Q. , Chen Weisan , Ramarathinam Sri H. , Lim Kam Sian Terry C.C. , Croft Nathan P. , Li Chen , Ayala Rochelle , Cebon Jonathan S. , Purcell Anthony W. , Schittenhelm Ralf B. , Behren Andreas
Published: April 2023

Table S6
Figure S6 from Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Authors: Wijewarnasuriya Dinali , Bebernitz Christina , Lopez Andrea V. , Rafiq Sarwish , Brentjens Renier J.
Published: April 2023

(A) B cells were assessed for CD80 expression by flow cytometry through peripheral blood. *p=0.048 unpaired t test of BM and *p=0.0233 unpaired t test of spleen. Data shown is mean +/- s.e.m. of two independent experiments. (B) Luminex data showing IL-4 secreting from EL4mCD19 tumor cells. Data shown is mean +/- s.e.m. of two independent experiments. *p=0.002 by unpaired t test. (C) Flow cytometry demonstrating lack of CD28 expression on CD28-/- T cells. Data shown is representative of two independent experiments. (D) CAR T cells were co-cultured with EL4mCD19 tumor cells and then assessed for cytotoxicity 4 hours later, using a luciferase killing assay. There was no difference in tumor lysis between CD28-/- or wildtype transduced CAR T cells. Data shown is mean +/- s.e.m. of two independent experiments.
Supplementary Figures from Remodeling Translation Primes CD8+ T-cell Antitumor Immunity
Authors: Hurst Katie E. , Lawrence Kiley A. , Robino Rob A. , Ball Lauren E. , Chung Dongjun , Thaxton Jessica E.
Published: April 2023

Supplementary Figs 1-4
Supplementary Table S3 from TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
Authors: Han Jiefei , Duan Jianchun , Bai Hua , Wang Yuqi , Wan Rui , Wang Xin , Chen Si , Tian Yanhua , Wang Di , Fei Kailun , Yao Zhuoran , Wang Shuhang , Lu Zhimin , Wang Zhijie , Wang Jie
Published: April 2023

Baseline characteristics of patients in the exploratory group (discovery set and validation set) and the control group.